Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Onconetix, Inc. (ONCO)

  • Technical Exchange News
  • Sept. 21, 2024, 01:46 UTC
  • 47
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Onconetix, Inc. (ONCO)

  • Technical Exchange News
  • Sept. 20, 2024, 19:20 UTC
  • 55
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Renovaro BioSciences Inc (RENB)

  • Technical Exchange News
  • Sept. 20, 2024, 02:04 UTC
  • 63
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

FibroGen Inc (FGEN)

  • Technical Exchange News
  • Sept. 20, 2024, 02:03 UTC
  • 48
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

CNS Pharmaceuticals Inc. (CNSP)

  • Technical Exchange News
  • Sept. 20, 2024, 02:03 UTC
  • 51
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Cognition Therapeutics Inc. (CGTX)

  • Technical Exchange News
  • Sept. 20, 2024, 02:03 UTC
  • 48
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Renovaro BioSciences Inc (RENB)

  • Technical Exchange News
  • Sept. 19, 2024, 18:41 UTC
  • 47
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

FibroGen Inc (FGEN)

  • Technical Exchange News
  • Sept. 19, 2024, 18:40 UTC
  • 46
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

CNS Pharmaceuticals Inc. (CNSP)

  • Technical Exchange News
  • Sept. 19, 2024, 18:40 UTC
  • 44
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Cognition Therapeutics Inc. (CGTX)

  • Technical Exchange News
  • Sept. 19, 2024, 18:40 UTC
  • 44
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text
  • Previous
  • 474
  • 475
  • 476
  • 477
  • 478
  • Next

Search

News categories

  • Technical Exchange News(11694)
  • Event(3945)
  • SEC News(230060)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(141290)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin